Charles River Laboratories | Marktkapitalisierung



Market Capitalization Veränderung Datum
Align Technology USD 15.57B 3.43B 2024-12
Bio-Rad Laboratories USD 9.18B 103M 2024-12
Bruker USD 8.89B 1.57B 2024-12
Cardinal Health USD 28.62B 1.88B 2024-12
Charles River Laboratories USD 9.44B 730M 2024-12
Cigna USD 76.81B 20.04B 2024-12
CVS Health USD 56.49B 22.61B 2024-12
Danaher USD 165.8B 34.99B 2024-12
Dentsply International USD 3.77B 1.71B 2024-12
Elevance Health USD 85.56B 35.02B 2024-12
Galapagos EUR 1.76B 51.29M 2024-12
Hologic USD 16.36B 2.56B 2024-12
Humana USD 30.55B 7.59B 2024-12
Illumina USD 21.19B 420M 2024-12
Incyte USD 13.31B 576M 2024-12
IQVIA Holdings USD 35.67B 7.53B 2024-12
Laboratory Of America USD 19.18B 452M 2024-12
Lonza CHF 38.78B 3.36B 2024-12
McKesson USD 72.34B 8.23B 2024-12
Merck EUR 68.69B 1.41B 2024-09
Mettler Toledo International USD 25.82B 6B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Quest Diagnostics USD 16.84B 442M 2024-12
Revvity USD 13.58B 2.17B 2024-12
Thermo Fisher Scientific USD 198.99B 37.61B 2024-12
United Therapeutics USD 15.75B 191M 2024-12
UnitedHealth USD 465.54B 74.37B 2024-12
Waters USD 22.03B 657M 2024-12
West Pharmaceutical Services USD 23.72B 1.95B 2024-12



Charles River Laboratories Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.